Delphinus Medical Technologies Lands $8,000,000 New Round

  • Feed Type
  • Date
    5/25/2010
  • Company Name
    Delphinus Medical Technologies
  • Mailing Address
    Hudson-Webber Cancer Research Center Detroit, MI 48201
  • Company Description
    Delphinus Medical Technologies, LLC., is a Michigan company and a spin-off of the Barbara Ann Karmanos Cancer Institute (KCI). Delphinus has succeeded in building a three-dimensional full-breast ultrasound imaging device that effectively differentiates benign from malignant masses in breast cancer cases using a safe (non-ionizing), comfortable (non-compressing), and reliable (operator independent) patented technology. Utilizing multi-parametric ultrasound and sophisticated computer algorithms, rather than X-rays, SoftVue safely and comfortably screens women for breast cancer, assesses breast cancer risk, diagnoses breast diseases and monitors therapy.
  • Website
    http://www.delphinusmt.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This research will further validate the initial findings in order to obtain approval from the U.S. Food and Drug Administration.
  • M&A Terms
  • Venture Investor
    Arboretum Ventures
  • Venture Investor
    Beringea
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.